IPRATROPIUM BROMIDE INHALATION SOLUTION.
Active substance(s): IPRATROPIUM BROMIDE
Ipratropium Bromide Inhalation Solution
(Ipratropium Bromide 250mcg/1ml and 500mcg/2ml)
Read all of this leaflet carefully before you start using this medicine.
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you. Do not pass it on to others. It may harm them,
even if their symptoms are the same as yours.
- If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet,
please tell your doctor or pharmacist.
In this leaflet:
1. What Ipratropium Bromide Inhalation Solution is and what it is used for
2. Before you use Ipratropium Bromide Inhalation Solution
3. How to use Ipratropium Bromide Inhalation Solution
4. Possible side effects
5. How to store Ipratropium Bromide Inhalation Solution
6. Further information
WHAT IPRATROPIUM BROMIDE INHALATION SOLUTION IS AND WHAT
IT IS USED FOR
The active substance in Ipratropium Bromide Inhalation Solution is called ipratropium bromide.
Ipratropium bromide belongs to a group of medicines known as bronchodilators. It is used to
treat breathing difficulties associated with wheezing, chest tightness or shortness of breath. It
works by opening up the air passages in your lungs so that you can breathe more easily.
BEFORE YOU USE IPRATROPIUM BROMIDE INHALATION SOLUTION
Do not use Ipratropium Bromide Inhalation Solution
- if you are allergic (hypersensitive) to ipratropium bromide, atropine or any of the other
ingredients of Ipratropium Bromide Inhalation Solution
Talk to your doctor before using this product if this applies to you.
Take special care with Ipratropium Bromide Inhalation Solution
- if you are pregnant
- if there is a chance you might become pregnant
- if you are breast-feeding
- if you are already taking another type of medicine by nebuliser
- if you suffer from an eye disorder called glaucoma
- if you suffer from an enlarged prostate
If any of the above apply to you, it is important that you tell your doctor or pharmacist before
using Ipratropium Bromide Inhalation Solution and they will decide what to do. It may still be
safe for you to use Ipratropium Bromide Inhalation Solution.
Taking other medicines
Please tell your doctor or pharmacist if you are taking or have recently taken any other
medicines, including medicines obtained without a prescription.
Using Ipratropium Bromide Inhalation Solution with food and drink
Food and drink have no known influence.
Pregnancy and breast-feeding
Ask your doctor or pharmacist for advice before using Ipratropium Bromide Inhalation Solution,
or any other medicine, during pregnancy or while breast-feeding.
Driving and using machines
Ipratropium Bromide Inhalation Solution may cause dizziness and blurred vision. Do not drive
or use machines until you know how it affects you.
HOW TO USE IPRATROPIUM BROMIDE INHALATION SOLUTION
Always use Ipratropium Bromide exactly as your doctor has told you. You should check with
your doctor or pharmacist if you are not sure.
First use of Ipratropium Bromide
The first time you use Ipratropium Bromide should be under close medical supervision.
The usual dose for adults and the elderly is 0.4–2.0ml up to 4 times daily. For children aged 3–
14 years the usual dose is 0.4–2.0ml up to 3 times daily.
Ipratropium Bromide must only be administered by inhalation from a suitable nebuliser. (This
product should not be swallowed). A nebuliser is a machine which turns the nebuliser solution
into a fine spray which you can then inhale, usually through a mask.
Preparing the nebuliser and Ipratropium Bromide Inhalation Solution:
1. Ensure that you are fully familiar with the operation of your nebuliser. Your doctor will
instruct you in how to correctly use the nebuliser and Ipratropium Bromide Inhalation
Solution. You should also carefully read the instructions provided with the nebuliser.
2. Prepare the nebuliser for use.
3. Separate a Steripoule from the strip by carefully pulling and twisting (Figure 1). Never use
one that is already open.
4. Hold the Steripoule upright and twist off the tab (Figure 2). Use the contents of the
Steripoule immediately after opening.
5. Squeeze the appropriate amount of the Steripoule contents (usually all contents) into the
nebuliser reservoir (Figure 3). If dilution is necessary, this should be carried out using only
sterile normal saline solution as instructed by your doctor.
6. Assemble the nebuliser and use it as instructed by your doctor. Care should be taken to
ensure that the nebuliser mist (or the solution) does not enter your eyes. Eye protection is
recommended for people with a history of glaucoma.
7. After nebulisation throw away any remaining solution and clean the nebuliser as instructed.
Diagrams to be inserted
If your treatment is less effective than usual
If your treatment is less effective than usual or the effect does not last as long as usual, do not
attempt to exceed your prescribed dose. You should contact your doctor immediately to discuss
If you use more Ipratropium Bromide Inhalation Solution than you should
If you have taken a slightly larger dose than recommended, you may develop an increased heart
rate and feel palpitations (your heart beat). This usually wears off after a few hours. However, if
you have taken a much larger dose than normal, you should contact either your doctor or your
nearest casualty department immediately for further advice. Take this leaflet and any remaining
medicine with you.
If you forget to use Ipratropium Bromide Inhalation Solution
If you forget an inhalation, take it when you remember. Do not take a double dose to make up
for a forgotten dose.
The next dose following this should be after your normal interval between doses (normally 6
If you stop using Ipratropium Bromide Inhalation Solution
Your doctor will advise you when to stop using Ipratropium Bromide Inhalation Solution.
Follow your doctor’s instructions.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
POSSIBLE SIDE EFFECTS
Like all medicines, Ipratropium Bromide Inhalation Solution can cause side effects, although not
everybody gets them.
There are rare, serious side effects and if you experience these you must stop using Ipratropium
Bromide Inhalation Solution immediately and contact your doctor. If you notice any of the
following side effects you may need urgent medical treatment.
You have difficulty breathing or become wheezy
Allergic reactions- signs may include skin rash, itching and nettle rash. In severe cases the
lips, mouth, face and tongue can swell along with sudden breathing difficulty and reduced
blood pressure. Tightening of your throat.
Palpitations (conscious awareness of your heartbeat), quickening of the heart rate or irregular
Increased heart rate
Stop using this medicine and see your doctor immediately if you have any of the above side
Other side effects include:
Common (affects less than 1 in 10 people)
- Headache, dizziness
- Unexpected tightness of the chest, cough and local irritation when you have just used
Ipratropium Bromide Inhalation Solution
- Dry mouth, diarrhoea, constipation, feeling or being sick
Uncommon (affects less than 1 in 100 people)
- Skin rash, itching of skin, nettle rash (urticaria)
- Blurred vision or difficulty focusing
- Increased pressure in your eyes (glaucoma)
Rare (affects less than 1 in 1000 people)
- Problems passing water (urine), especially if you already have problems passing urine.
If any of the liquid or mist accidentally gets into your eyes you may get painful, stinging or red
eyes, blurred vision or dilated pupils. You may also see colours or lights. If this happens or you
experience any of these side effects, talk to your doctor for advice. If affected do not drive or
use any tools or machinery. If you get any problems with your eyes at any other time, talk to
your doctor for advice.
If any of the side effects above gets serious, or if you notice any side effects not listed in this
leaflet, please tell your doctor or pharmacist.
HOW TO STORE IPRATROPIUM BROMIDE INHALATION SOLUTION
Keep out of the reach and sight of children.
Do not use Ipratropium Bromide Inhalation Solution after the expiry date, which is stated on the
carton, foil bag and plastic ampoules. The expiry date refers to the last day of that month.
Store the product below 25oC. Keep the Steripoules in the foil bag within the carton in order to
protect the product from light and moisture.
Do not use Ipratropium Bromide Inhalation Solution if you notice that the packaging or any of
the plastic ampoules are damaged, or if the solution in the plastic ampoules is no longer clear and
Do not keep or use a Steripoule which has been opened previously – throw it away.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist
how to dispose of medicines no longer required. These measures will help to protect the
What Ipratropium Bromide Inhalation Solution contains
The active substance is called ipratropium bromide. Each Steripoule contains either 250
micrograms of ipratropium bromide in 1ml (250mcg/1ml) or 500 micrograms of ipratropium
bromide in 2ml (500mcg/2ml).
The other ingredients in the Steripoules are: dilute sulphuric acid, sodium hydroxide solution,
sodium chloride and water for injections.
What Ipratropium Bromide Inhalation Solution looks like and the contents of the pack
Each carton of Ipratropium Bromide contains either 20 or 60 plastic ampoules (Steripoules)
packed in strips of 10 Steripoules. Each strip is individually wrapped in a foil bag. Each
Steripoule contains 1ml or 2ml of a clear, colourless solution for use only through a nebuliser.
Marketing Authorisation Holder
Focus Pharmaceuticals Ltd
Unit 5, Faraday Court
First Avenue, Centrum 100
Burton upon Trent
DE14 2WX, UK
Almac Pharma Services Limited
20 Seagoe Industrial Estate
This leaflet was last revised in April 2011.
Source: Medicines and Healthcare Products Regulatory Agency
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.